« Back
Home /
Mizoribine

Mizoribine

Item no.	M1921-1g
Manufacturer	AbMole
CASRN	50924-49-7
Amount	1g
Category	Food Safety Histamines Metabolism Cholesterol & Lipid Metabolism Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98.5%
Citations	Mizoribine treatment for antihistamine-resistant chronic autoimmune urticaria. Hashimoto T, et al . Dermatol Ther. 2012 Jul-Aug,25(4):379-81. PMID: 22950565 . The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis. Takeuchi S, et al . Nephron Exp Nephrol. 2010,116(1):e3-10. PMID: 20502051 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Bredinin
Similar products	Mizoribine, Bredinin
Available
Target Information	DNA/RNA Synthesis
Molecular Weight	259, 22
Solubility	Water ≥ 30 mg/mL
Bioactivity information	Mizoribine (Bredinin) is an imidazole nucleoside and an immunosuppressive agent with an IC50 of approximately 100 μM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1921-1g-safety-datasheet.pdf